Panacea Biotec touches the roof on bagging additional order from UNICEF

24 Apr 2025 Evaluate

Panacea Biotec is locked its upper circuit limit at Rs. 538.90, up by 25.65 points or 5.00% from its previous closing of Rs. 513.25 on the BSE.

The scrip opened at Rs. 524.05 and has touched a high and low of Rs. 538.90 and Rs. 520.15 respectively. So far 35427 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 549.05 on 21-Apr-2025 and a 52 week low of Rs. 112.70 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 549.05 and Rs. 496.85 respectively. The current market cap of the company is Rs. 3294.07 crore.

The promoters holding in the company stood at 72.48%, while Institutions and Non-Institutions held 2.65% and 24.87% respectively.

Panacea Biotec has bagged additional order from United Nations International Children's Emergency Fund (UNICEF) for supply of 40 million doses of its bivalent oral polio vaccine (bOPV) worth around $5.20 million (around Rs 44 crore) in Q3CY2025. 

Panacea Biotec is a leading research-based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

344.65 -0.10 (-0.03%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×